Cingulate Inc. (CINGW) Stock Price & Analysis
Cingulate Inc. (CINGW) rose 0.00% to USD 0.02 as of July 26, 2026 at 11:51 UTC, according to Nexqual real-time market data.
CINGW last closed at USD 0.02; the session ranged USD 0.02–0.02 on volume of 12,287 shares. Market capitalization is —, with a 52-week range of USD 0.02–0.02 (NCM). Source: Nexqual, July 26, 2026 at 11:51 UTC.
Key Statistics (as of July 26, 2026 at 11:51 UTC)
| Price | USD 0.02 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.02 |
| Open | USD 0.02 |
| Day Range | USD 0.02 – 0.02 |
| 52-Week Range | USD 0.02 – 0.02 |
| Volume | 12,287 shares |
| Market Cap | — |
| Exchange | NCM |
From Cingulate Inc.'s Latest SEC 10-K Filing (filed 2026-03-18)
Key Strengths & Strategy (as disclosed to the SEC)
- Roberts served as the Chief Financial Officer for VirMedica, Inc., a company that provides an end-to-end platform that enables specialty drug manufacturers and pharmacies to optimize product commercialization and management.
Partnerships
- Schaffer   On September 23, 2021, we entered into an employment agreement with Dr.
- Callahan   On January 25, 2024, we entered into an employment agreement with Ms.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CING | Cingulate Inc. | USD 4.64 | ▼ 4.13% |
| CELUW | Celularity Inc. | USD 0 | ▲ 0% |
| DRMAW | Dermata Therapeutics, Inc. Warrant | USD 0.01 | ▼ 4.81% |
| DRTSW | Alpha Tau Medical Ltd. Warrant | USD 3.18 | ▼ 9.92% |
| NRSNW | NEUROSENSE THERAPEUTICS LTD C/W | USD 0.06 | ▼ 0.17% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 11:51 UTC. This page is informational and not investment advice.